On November 12to-13, 2014, BioCentury held a China health summit in Shanghai with the theme of " bridge of innovation". The conference presented the "BayHelix Award for R&D Achievement of the Year 2014" award to Shenzhen CHIPSCREEN BIOSCIENCES in recognition of the original contribution of original new drug Chidamide of Shenzhen CHIPSCREEN BIOSCIENCES to the global epigenetic regulation and control field, as well as the outstanding contribution of China's first original chemical drug to the global T lymphoma treatment field.

Baihua Association is a non-profit and membership-only organization. The mission of the association members is to promote the development of life science and medical health in China. Founded in 2001, the Baihua Association has developed more than 500 elite members from the United States, Canada and China. Its members are all over the world's top pharmaceutical and biopharmaceutical companies. at the same time, they also come from leading service and investment firms. More than a third of the members are senior executives, more than 80 % have Ph.D. degrees in life sciences, and nearly half are MBA students from top US business schools.